PROSPECTIVE PHASE II TRIAL OF A COMBINATION OF GEMCITABINE AND UFT AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Baek, J. H. [1 ]
Kim, H. [1 ]
Kim, H. J. [1 ]
Park, J. [1 ]
Min, Y. J. [1 ]
机构：
[1] Ulsan Univ Hosp, Ulsan, South Korea
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer
    Baek, Jin Ho
    Kim, Hawk
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Ra, Seung Won
    Park, Chang Ryul
    Jung, Jong Pil
    Kim, Jeong Won
    Lee, Yong Jik
    Cha, Hee Jeong
    Kwon, Woon Jung
    Noh, Young Ju
    Oh, Sukjoong
    Park, Jae-Hoo
    Min, Young Joo
    [J]. LUNG CANCER, 2012, 76 (03) : 368 - 372
  • [2] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer
    Baek, J.
    Ahn, J.
    Jegal, Y.
    Park, C.
    Lee, Y.
    Cha, H.
    Kwon, W.
    Noh, Y.
    Park, J.
    Min, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S621 - S621
  • [3] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Baek, Jin Ho
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Park, Chang Ryul
    Lee, Yong Jik
    Cha, Hee Jeong
    Kwon, Woon Jung
    Noh, Young Ju
    Min, Young Joo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S400 - S400
  • [4] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Shin, S. J.
    Min, Y. J.
    Baek, J. H.
    Kim, H.
    Ann, J. J.
    Jegal, Y. J.
    Park, C. Y.
    Cha, H. J.
    Kwon, W. J.
    Park, J. H.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 381 - 381
  • [5] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Jin, S. S.
    Min, Y.
    Kim, H.
    Ahn, J.
    Jegal, Y.
    Seo, K.
    Park, C.
    Shin, J.
    Cha, H.
    Kwon, W.
    Park, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [7] Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma
    Shin, Su Jin
    Kim, Hawk
    Baek, Jin Ho
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Park, Chang Ryul
    Shin, Je Kyoun
    Jung, Jong Pil
    Kim, Jeong Won
    Cha, Hee Jeong
    Kwon, Woon Jung
    Jeong, Ae Kyung
    Noh, Young Ju
    Park, Jae-Hoo
    Min, Young Joo
    [J]. LUNG CANCER, 2008, 60 (01) : 83 - 91
  • [8] An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients
    Tredaniel, J.
    Becht, C.
    Bekradda, M.
    De Cremoux, H.
    Alexandre, J.
    Chomy, F.
    Szyldergemajn, S.
    Yataghene, Y.
    Culine, S.
    [J]. LUNG CANCER, 2009, 63 (02) : 259 - 263
  • [9] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [10] Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Sujith Kalmadi
    Giles McNeill
    Mellar Davis
    David Peereboom
    David Adelstein
    Tarek Mekhail
    [J]. Medical Oncology, 2006, 23 : 507 - 513
12345